CD1E

CD1e is a non-classical, beta2-microglobulin-associated member of the CD1 lipid-antigen presentation family that, unlike its relatives, never reaches the cell surface and instead acts as an intracellular lipid transfer/editing protein controlling group 1 and group 2 CD1-restricted T cell responses (PMID:10948205, PMID:16311334, PMID:21844346). Synthesized as alternatively spliced isoforms, the three-alpha-domain forms assemble with beta2-microglobulin and accumulate in the late Golgi of immature dendritic cells, then redistribute to lysosomes upon DC maturation; this trafficking proceeds through sorting endosomes entirely without transit through the plasma membrane (PMID:10948205, PMID:15752135, PMID:36460227). The cytoplasmic tail governs this itinerary: its C-terminal half drives Golgi accumulation, while ubiquitination of cytoplasmic lysines triggers Golgi exit and delivery to lysosomes, where CD1e is cleaved into a stable soluble form (PMID:10948205, PMID:18208508). The soluble lysosomal protein functions as a lipid transfer protein with a structurally widened groove portal, no fixed endogenous ligand, and fast lipid on/off kinetics relative to CD1b (PMID:21788486). Functionally, it assists lysosomal alpha-mannosidase digestion of complex mycobacterial phosphatidylinositol mannosides (PIM6) into immunogenic forms recognized by CD1b-restricted T cells, doing so in an acylation-dependent manner and selectively transferring diacylated PIM species to CD1b (PMID:16311334, PMID:22782895). More broadly, CD1e accelerates assembly and turnover of CD1b, CD1c, and CD1d–lipid complexes, thereby maximizing but temporally narrowing CD1-restricted T cell responses (PMID:21844346). A natural allele 4 variant bearing a proline at position 194 abolishes PIM6 presentation due to defective assembly and late-endosomal transport (PMID:18325888).

1. 2000 High

   Established that CD1e is structurally and behaviorally distinct from other CD1 proteins, defining it as an intracellularly retained, beta2-microglobulin-associated molecule that is proteolytically converted to a soluble form rather than displayed at the surface.

   Evidence Isoform construct transfection, subcellular fractionation, and confocal microscopy in cells and dendritic cells

   PMID:10948205

   Open questions at the time

   • Functional role of the soluble cleaved form not yet defined
   • Mechanism triggering Golgi-to-endosome redistribution upon maturation unresolved
2. 2003 Medium

   Showed the intracellular retention, beta2m association, and soluble cleavage of CD1e are evolutionarily conserved between human and macaque, arguing these unusual features are functionally important rather than incidental.

   Evidence Comparative biochemical and localization analysis in human and rhesus macaque cells

   PMID:12671734

   Open questions at the time

   • Conservation does not by itself reveal molecular function
   • Single comparative lab study
3. 2005 High

   Resolved the trafficking route, demonstrating CD1e reaches lysosomes via sorting endosomes without surface transit and progressively localizes to CD1b+ lysosomal compartments, placing it in the right place to act on CD1b presentation.

   Evidence Live-cell imaging, confocal and immunoelectron microscopy, and fractionation in immature and LPS-matured dendritic cells

   PMID:15752135

   Open questions at the time

   • Molecular sorting signals not yet identified at this stage
   • Protease responsible for soluble cleavage unknown
4. 2005 High

   Assigned the first molecular function to soluble CD1e, showing it is required to assist lysosomal alpha-mannosidase digestion of mycobacterial PIM6 into forms presentable by CD1b-restricted T cells, and that it binds glycolipids directly.

   Evidence CD1b-restricted T cell stimulation assays, in vitro recombinant CD1e plus alpha-mannosidase digestion, and glycolipid binding assays

   PMID:16311334

   Open questions at the time

   • Whether CD1e directly transfers lipids or only assists digestion not resolved here
   • Structural basis of glycolipid binding unknown
5. 2008 High

   Defined the trafficking code in the cytoplasmic tail, showing Golgi retention maps to the C-terminal half and that ubiquitination of cytoplasmic lysines is the switch driving Golgi exit and lysosomal delivery.

   Evidence Chimeric and lysine-to-arginine mutant constructs, ubiquitin-fusion rescue, immunofluorescence and fractionation in transfected cells

   PMID:18208508

   Open questions at the time

   • Identity of the responsible ubiquitin ligase not determined
   • Link between maturation signals and tail ubiquitination unresolved
6. 2008 High

   Connected CD1e function to natural genetic variation, showing the allele 4 P194 variant fails to support PIM6 presentation because of defective assembly and impaired late-endosomal transport.

   Evidence T cell stimulation, immunofluorescence localization, and biochemical assembly analysis of allele 4 versus wild-type in transfected cells

   PMID:18325888

   Open questions at the time

   • Population-level immunological consequences of allele 4 not established
   • Whether assembly defect affects all CD1e functions or only PIM6 unclear
7. 2011 High

   Provided the structural and mechanistic foundation for lipid transfer, showing a widened, ligand-promiscuous groove and fast lipid kinetics that allow CD1e to load and displace lipids on CD1b.

   Evidence 2.90-A X-ray crystallography, native mass spectrometry, and in vitro lipid transfer and kinetic binding assays

   PMID:21788486

   Open questions at the time

   • No fixed endogenous ligand identified
   • Structural states during active lipid handoff not captured
8. 2011 High

   Generalized CD1e function beyond CD1b, demonstrating it can positively or negatively modulate CD1b, CD1c, and CD1d lipid presentation by accelerating both assembly and turnover of CD1-lipid complexes.

   Evidence T cell stimulation, CD1-lipid complex kinetics assays, and a CD1e transgenic mouse antigen-presenting cell model

   PMID:21844346

   Open questions at the time

   • Determinants of positive versus negative modulation per CD1 isoform unclear
   • In vivo physiological consequences for T cell repertoire not defined
9. 2012 High

   Refined the lipid transfer mechanism, showing selectivity is dictated by acylation state—CD1e assists alpha-mannosidase digestion and transfers diacylated PIM species while excluding others.

   Evidence In vitro liposome lipid transfer, alpha-mannosidase digestion, CD1b loading assays, and mass spectrometry of PIM species

   PMID:22782895

   Open questions at the time

   • Structural basis of acyl-chain selectivity not determined
   • Range of physiological lipid substrates beyond PIM not mapped
10. 2012 Medium

    Identified LAPTM5 as a physical partner colocalizing with CD1e in trans-Golgi and late endosomes, while excluding it as a controller of CD1e ubiquitination or soluble form generation.

    Evidence Reciprocal co-immunoprecipitation, confocal colocalization, bafilomycin treatment and ubiquitination assays in a dendritic cell model

    PMID:22880058

    Open questions at the time

    • Functional consequence of the LAPTM5 interaction unknown
    • Single-lab interaction without independent confirmation
11. 2022 Medium

    Confirmed by direct biophysics that CD1e binds beta2-microglobulin, validating with purified proteins the association previously inferred from cell-based studies.

    Evidence Cell-free synthesized CD1e and B2M, Ni2+ purification, and surface plasmon resonance binding

    PMID:36460227

    Open questions at the time

    • Binding affinity and stoichiometry in physiological context not established
    • Single method, single lab

• How CD1e maturation signals trigger tail ubiquitination, which ligase and protease act on it, and how it chooses to enhance versus suppress specific CD1 isoforms in vivo remain open.
• No ubiquitin ligase or cleaving protease identified
• Physiological rules governing positive versus negative CD1 modulation undefined
• In vivo immune consequences of human CD1e variants unmapped